Nathaniel Lowe hit two home runs, James Wood and Luis Garcia Jr. hit back-to-back long balls in the fourth inning and the ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

From the outset, the cast of the television series MASH was a solid ensemble of performers, led by Alan Alda, who ...

Michter’s 2025 Legacy Series features two limited releases: Bomberger’s Declaration Kentucky Straight Bourbon (54% ABV) and ...

Rivus Pharmaceuticals’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the ...

With his home run in Thursday’s 3-1 victory over the Rockies, Ohtani became one of only three Dodgers’ hitters to mash 28 ...

First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of fibrosis ...

Shares of Altimmune tumbled after the company failed to achieve statistical significance on one of the dual primary endpoints in a recent trial evaluating its drug, pemvidutide, for metabolic ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) and Viking Therapeutics (NASDAQ:VKTX) were among notable gainers on Thursday as ...

Michter's Distillery will be releasing its Shenk's Homestead Kentucky Sour Mash Whiskey and Bomberger's Declaration Kentucky ...

Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a treatment for metabolic ...